Postherpetic Neuralgia
📧 Sign up to get email alerts when something new happens for Postherpetic Neuralgia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-06-24Clinical Trial Update: The Effect of Epidural Steroid Use in Patients With Continous Epidural Block in PHN Patients. [Phase 4]
Phase 4 clinical trial examining the effect of epidural steroid use in patients with continuous epidural block for postherpetic neuralgia (P…
-
FDA approval · 2019-05-23FDA Approved: LYRICA — Supplemental Application (Parke-Davis Div of Pfizer Inc)
FDA approved a supplemental application for LYRICA (pregabalin) submitted by Parke-Davis Div of Pfizer Inc, indicating an approved modificat…
-
CLINICAL_TRIALS withdrawal · 2019-02-12Clinical Trial Update: The Evaluation of Erector Spinae Plane Block for the Pain Control of Thoracic Postherpetic Neuralgia [NA]
Clinical trial evaluating erector spinae plane block for pain control in thoracic postherpetic neuralgia has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2019-01-31Clinical Trial Update: A Study Assessing Efficacy of Brivaracetam in Subjects With Persistent Pain After Shingles (Post-herpetic Neuralgia) [Phase 2]
Phase 2 trial evaluating brivaracetam for postherpetic neuralgia has completed and results have been posted.
-
FDA approval · 2018-11-02FDA Approved: ZTLIDO — Supplemental Application (Scilex Pharmaceuticals Inc.)
FDA approved a supplemental application for ZTLIDO (lidocaine topical system) by Scilex Pharmaceuticals, updating its labeling.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-10-23Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Topically Applied TV 45070 Ointment in Patients With Postherpetic Neuralgia (PHN) [Phase 2]
Phase 2 trial completed evaluating safety and efficacy of Topically Applied TV 45070 Ointment for postherpetic neuralgia.
-
CLINICAL_TRIALS trial_result · 2018-10-23Clinical Trial Update: Mannitol Cream for Post Herpetic Neuralgia [Phase 1, Phase 2]
Clinical trial update on Mannitol Cream for postherpetic neuralgia across Phase 1 and Phase 2 (completed).
-
FDA approval · 2018-10-16FDA Approved: GABAPENTIN — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved the original generic application for gabapentin, enabling a generic version of the anticonvulsant for the same indications as t…
-
CLINICAL_TRIALS trial_result · 2018-08-10Clinical Trial Update: Acupuncture in Herpes Zoster Neuralgia (ACUZoster) [Phase 4]
Phase 4 clinical trial update assessing acupuncture for herpes zoster neuralgia and postherpetic neuralgia has completed.
-
CLINICAL_TRIALS trial_result · 2018-07-10Clinical Trial Update: 3VM1001 Cream for the Treatment of Pain Associated With Post Herpetic Neuralgia (PHN) [EARLY_Phase 1]
The early Phase 1 trial of 3VM1001 Cream for postherpetic neuralgia has been completed. Sponsor: CDA Research Group, Inc.
-
FDA approval · 2018-05-14FDA Approved: GABAPENTIN — Original Application (ACI Healthcare USA, Inc.)
FDA approved an Original Application (ANDA) for Gabapentin by ACI Healthcare USA, Inc., authorizing a generic gabapentin product.
-
CLINICAL_TRIALS trial_result · 2018-05-01Clinical Trial Update: An Effectiveness and Safety Study With RWJ-333369 (Carisbamate) for the Study of Postherpetic Neuralgia (PHN). [Phase 2]
Phase 2 trial update reports effectiveness and safety findings for carisbamate (RWJ-333369) in postherpetic neuralgia, with the study comple…
-
CLINICAL_TRIALS trial_result · 2018-04-23Clinical Trial Update: A Study to Compare QUTENZA With Pregabalin for the Treatment of Peripheral Neuropathic Pain (PNP) After 8 Weeks of Treatment [Phase 4]
A completed Phase 4 study comparing QUTENZA (capsaicin 8% patch) with pregabalin for peripheral neuropathic pain over 8 weeks, including non…
-
CLINICAL_TRIALS trial_result · 2018-04-23Clinical Trial Update: Method of Pre-treatment for Application of QUTENZA Capsaicin 8% Patch [Phase 4]
Phase 4 trial update evaluating pre-treatment methods for applying the QUTENZA 8% capsaicin patch; study sponsored by Astellas has completed…
-
CLINICAL_TRIALS trial_result · 2018-04-19Clinical Trial Update: Safety and Effectiveness of Repeated Administration of QUTENZA Patches for Treatment of Pain Caused by Nerve Damage [Phase 4]
A Phase 4 trial evaluated the safety and effectiveness of repeated QUTENZA patches (capsaicin 8% patch) for neuropathic pain due to nerve da…
-
CLINICAL_TRIALS trial_result · 2018-04-04Clinical Trial Update: Scrambler Therapy in Treating Chronic Pain in Patients With Rash From Varicella Zoster Virus Infection [NA]
A completed Mayo Clinic-sponsored trial evaluating scrambler therapy for chronic pain in patients with a rash due to Varicella Zoster virus …
-
FDA approval · 2018-02-28FDA Approved: ZTLIDO — Original Application (Scilex Pharmaceuticals Inc.)
FDA approved ZTLIDO, a lidocaine topical patch, under an original NDA from Scilex Pharmaceuticals. It is indicated for the management of pai…
-
FDA approval · 2017-12-27FDA Approved: GABAPENTIN — Supplemental Application (Creekwood Pharmaceuticals LLC)
The FDA approved a supplemental application for gabapentin submitted by Creekwood Pharmaceuticals LLC. The approval covers changes to an alr…
-
CLINICAL_TRIALS trial_result · 2017-12-22Clinical Trial Update: A Comparative Study of FV-100 vs. Valacyclovir for the Prevention of Post-Herpetic Neuralgia [Phase 3]
Phase 3 trial comparing FV-100 to Valacyclovir for preventing post-herpetic neuralgia was terminated.
-
CLINICAL_TRIALS trial_result · 2017-11-08Clinical Trial Update: A Study Into Pain Relief Given by ASP8477 for Peripheral Neuropathic Pain (Either Post-herpetic Neuralgia or Painful Diabetic Peripheral Neuropathy) and Its Safety [Phase 2]
Phase 2 study evaluating ASP8477 for relief of peripheral neuropathic pain and safety in post-herpetic neuralgia and painful diabetic periph…
-
FDA approval · 2017-10-26FDA Approved: GABAPENTIN — Original Application (Precision Dose, Inc.)
FDA approved the original application for gabapentin from Precision Dose, Inc., establishing a generic version of the anticonvulsant.
-
FDA approval · 2017-10-18FDA Approved: NEURONTIN — Supplemental Application (Parke-Davis Div of Pfizer Inc)
The FDA approved a supplemental application for Neurontin (gabapentin) filed by Parke-Davis Div of Pfizer Inc. The approval concerns a modif…
-
FDA approval · 2017-10-11FDA Approved: LYRICA CR — Original Application (Viatris Specialty LLC)
FDA approves LYRICA CR (pregabalin) under an Original Application for an extended-release formulation of pregabalin.
-
CLINICAL_TRIALS trial_result · 2017-08-03Clinical Trial Update: Association of Transcutaneous Electrical Nerve Stimulation and Hypnosis [NA]
A completed clinical trial evaluating the combination of transcutaneous electrical nerve stimulation (TENS) and hypnosis for various chronic…
-
CLINICAL_TRIALS research · 2017-06-14Clinical Trial Update: Pregabalin Treatment and Prevention Post-herpetic Neuralgia [Phase 3]
Phase 3 clinical trial update for pregabalin in postherpetic neuralgia; current trial status is unknown.